What happens if I want to stop treatment
doi:10.1177/10600280251407145
JAMA Netw Open 7(10):e2439887e2439887 Wang L, Wang W, Kaelber DC, Xu R, Berger NA (2024) GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity
Due to this, many people find Zepbound injections highly effective and sometimes associated with fewer side effects, though results and reactions can vary between individuals
Physiological functions [edit source] GLP-1 possesses several physiological properties making it (and its functional analogs) a subject of intensive investigation as a potential treatment of diabetes mellitus, as these actions induce long-term improvements along with the immediate effects
Some GLP-1 users report low energy from eating less, while others find they have fewer crashes, perhaps because of better blood sugar regulation